Trial Profile
Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2022
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Acronyms TIMES-2
- Sponsors Kyowa Kirin
- 06 Jan 2012 Actual end date changed from Jun 2008 to Aug 2008 as reported by ISRCTN: Current Controlled Trials
- 30 Mar 2011 Results have been published in Diabetes Care, according to a ProStrakan media release.
- 18 Jun 2008 Testosterone gel is expected to be filed for approval in the US in the second half of 2008, according to a ProStrakan media release..